Fundraise / allotmentFiled on BSE ·
Bharat Parenterals Limited approves preferential allotment of 9.13 lakh equity shares
Bharat Parenterals Ltd · Pharmaceuticals & Biotechnology
What the filing says
- Board approved issue of 9,12,759 equity shares at ₹1522.85 each for ₹139 crore on Sept 29, 2026
- Shares to be allotted to 15 non-promoter investors including WhiteOak Capital funds and individuals
- Extraordinary General Meeting scheduled for Oct 23, 2026 to seek shareholder approval
Original filing
Board Meeting Outcome for Outcome Of Board Meeting For The Board Approves The Preferential Issue.
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies
Electrical Equipment
Revenue: Rank 1Margin: Rank 1
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Bharat Parenterals Ltd
- Fundraise / allotmentBharat Parenterals Limited announces Board meeting on September 29, 2026
Other fundraise / allotment filings this fortnight
- Fundraise / allotmentInox GreenInox Green Energy Services Ltd allotted 1.81 crore equity shares via QIP in Sept 2026
- Fundraise / allotmentInox GreenInox Green Energy Services completes Qualified Institutions Placement on Sept 29, 2026
- Fundraise / allotmentAurum Proptech LtdAurum PropTech allots 1.98 crore equity shares to REA India on preferential basis
- Fundraise / allotmentAurum Proptech LtdAurum PropTech Limited allots 1.98 crore shares to REA India on preferential basis
- Fundraise / allotmentRepco Home FinRepco Home Finance approved raising ₹1500 Cr NCDs and ₹1000 Cr Commercial Paper
- Fundraise / allotmentD.P. Abhushan LtdD. P. Abhushan Limited board meeting on Oct 5, 2026 to consider fund raising
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.
